K Number
K103090
Manufacturer
Date Cleared
2010-11-19

(31 days)

Product Code
Regulation Number
N/A
Panel
GU
Reference & Predicate Devices
N/A
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Spectra Optia Apheresis System, a blood component separator, is intended for use in therapeutic plasma exchange.

Device Description

The Spectra Optia Apheresis System is a centrifugal system that separates whole blood into its cellular and plasma components. The system is used therapeutically to remove and exchange blood plasma in patients who suffer from adverse hematologic and other conditions.

The system includes a disposable Exchange Set through which the patient's blood passes. and a machine that controls the separation of blood into its components and monitors the exchange procedure for patient safety. The Spectra Optia machine and its embedded software have been modified to include and support a return line air detector, respectively. The return line air detector serves as a backup air detection system and represents an enhancement to the system's overall safety profile. This additional sensor actively monitors the return line and detects the presence of air, prior to its reaching the patient. In the unlikely event that the extracorporeal circuit is improperly anticoagulated and clotted material in the disposable set interferes with the system's primary air detection sensors, the modified device "alarms" when air is detected and instructs the operator to clear the return line. Because the operator must clear the line before the apheresis procedure can be continued, patients are protected from receiving potentially unsafe quantities of air - even when the operator has sub-optimally anticoagulated the circuit. In the further unlikely event that the operator disregards the system's instructions to clear air in the line, the software safely terminates the apheresis procedure.

AI/ML Overview

The provided document describes a 510(k) submission for a modification to the Spectra Optia® Apheresis System to include a return line air detector. The submission is a special 510(k), indicating that the change does not alter the fundamental technology or intended use of the device.

Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance:

The document does not explicitly state formal, quantitative acceptance criteria in a tabular format, nor does it provide specific numerical performance metrics. Instead, it describes 4 activities to verify correct functioning. These activities served as the basis for demonstrating that the device meets its intended safety enhancement.

Acceptance Criterion (Inferred)Reported Device Performance
No interference of ultrasonic sensor with machine/disposable interaction"Physical testing of the modified Spectra Optia machine to ensure that the ultrasonic sensor does not interfere with the interaction between the Spectra Optia machine and the disposable Exchange Set." (Implied successful demonstration of no interference)
Correctness of software algorithms and code"Software code reviews and unit tests to ensure that algorithms and other code were written correctly and yield the expected results." (Implied successful verification of code correctness and expected results)
Correct function of modified software and hardware"Integration tests to ensure that the modified software and hardware function correctly." (Implied successful demonstration of integrated functionality)
Consistent functioning of backup air detection system"Simulated use tests to ensure that the backup air detection system consistently functions as expected. In the further unlikely event that the operator disregards the system's instructions to clear air in the line, the software safely terminates the apheresis procedure." (Implied successful and consistent detection of air, triggering alarms, and safe termination if instructions are ignored.)

2. Sample Size Used for the Test Set and Data Provenance:

  • Sample Size: The document does not specify a numerical sample size for any of the tests (physical testing, software tests, integration tests, simulated use tests). It uses general terms like "Extensive laboratory testing" and "simulated use tests."
  • Data Provenance: The testing appears to be prospective laboratory testing and simulation, conducted internally by the manufacturer (CaridianBCT, Inc.). There is no mention of country of origin of data as it's not clinical data from patients.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications:

The document does not mention the use of external experts or a ground truth established by a panel of experts for the technical and functional testing described. The "ground truth" for these tests would have been based on established engineering specifications, software requirements, and safety protocols defined by the manufacturer.

4. Adjudication Method for the Test Set:

Not applicable. The testing described focuses on engineering verification and validation (V&V) rather than subjective interpretation by multiple human readers. Therefore, an adjudication method for different human interpretations is not relevant.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

Not applicable. This device modification is for a safety feature (air detection) in an apheresis system, not for a diagnostic imaging or interpretive task where human readers would be evaluating cases. The study focuses on the technical functionality of the air detector, not improvement in human reader performance.

6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study:

Yes, essentially. The verification and validation activities described, particularly "Software code reviews and unit tests" and "Simulated use tests," evaluate the system's performance (including the modified software and hardware) independently of a human operator's actions, except for the scenario where the operator fails to follow instructions, in which case the system is designed to safely terminate. The focus is on the correct functioning of the air detection mechanism and the system's automated response.

7. Type of Ground Truth Used:

The ground truth used for these tests was based on:

  • Engineering Specifications: Ensuring the ultrasonic sensor does not interfere.
  • Software Requirements: Verifying algorithms and code yield expected results.
  • System Design Specifications: Confirming integrated hardware/software function.
  • Safety Protocols: Demonstrating consistent detection of air and appropriate (safe) system responses during simulated use.

This is a technical/functional ground truth rather than a clinical ground truth like pathology or patient outcomes.

8. Sample Size for the Training Set:

Not applicable. This document describes the validation of a hardware and software modification to an existing device, not the development of a machine learning algorithm that requires a training set. The "software code reviews and unit tests" refer to standard software development practices, not AI model training.

9. How the Ground Truth for the Training Set Was Established:

Not applicable, as no training set for a machine learning algorithm was used.

N/A